|
|
| |
|
Healthcare News from Around the Nation
|
After Cancellations, 1,200 Californians Get Health Insurance Back
Friday, May 16, 2008, 9:12 pm ET; Source: The Wall Street Journal
Published: 5/16/2008
The health insurance pendulum is swinging back the other way in California.
|
Opening Glance: Healthcare Stocks Edge Up
Friday, May 16, 2008, 10:45 pm ET; Source: AP via Yahoo!
Published: 5/16/2008
Health care providers and service company stocks mostly traded higher Friday morning, with insurers bouncing back from their losses a day earlier.
|
Opening Glance: Pharmaceuticals
Friday, May 16, 2008, 9:54 pm ET; Source: AP via Yahoo!
Published: 5/16/2008
Shares of large pharmaceutical companies lacked direction in early Friday trading. The broader market slipped as investors digested new record highs for oil and a surprising jump in new home construction.
|
Dynavax Shares Plummet on Allergy Drug Failure
Friday, May 16, 2008, 9:52 pm ET; Source: AP via Yahoo!
Published: 5/16/2008
Shares of Dynavax Technologies Corp. plummeted Friday after the drug developer said it is ending development of its ragweed allergy drug Tolamba after it failed a midstage trial.
|
Opening Glance: Biotechnology
Friday, May 16, 2008, 9:50 pm ET; Source: AP via Yahoo!
Published: 5/16/2008
Shares of large-cap biotechnology companies opened mostly higher Friday, as positive data abstracts from Genentech and ImClone started to be released ahead of the American Society of Clinical Oncology Conference in Chicago.
|
Multaq Sparks A Change Of Heart For Sanofi
Friday, May 16, 2008, 8:45 pm ET; Source: Forbes.com
Published: 5/16/2008
Sanofi-Aventis, one of the batch of pharmaceutical behemoths under pressure from low-cost generics, managed to win back the hearts of investors Friday after it announced positive clinical trial results for its breakthrough heart drug Multaq.
|
Genentech's Avastin Passes Key Safety Test
Friday, May 16, 2008, 7:33 pm ET; Source: TheStreet.com
Published: 5/16/2008
Genentech said late Thursday that its late-stage trial on Avastin in early-stage colon cancer patients passed a recent safety check and it now expects final data a year earlier than previously thought.
|
Lilly Drug Shown to Slow Lung Cancer
Friday, May 16, 2008; Source: The Wall Street Journal
Published: 5/16/2008
Eli Lilly & Co.'s Alimta delayed growth in lung cancer when used soon after initial chemotherapy, a new study concluded.
|
Analyst: $850M Opportunity for Allscripts With Merger
Thursday, May 15, 2008, 5:49 pm ET; Source: AP via Yahoo!
Published: 5/16/2008
Shares of Allscripts Healthcare Solutions Inc. rose Thursday after a Piper Jaffray analyst said the clinical software provider's merger with the healthcare division of British software company Misys PLC will provide an $850 million market opportunity for Allscripts.
|
Moody's changes CVS outlook to positive
Thursday, May 15, 2008, 6:29 pm ET; Source: AP via Yahoo!
Published: 5/16/2008
Credit-ratings agency Moody's Investors Service on Thursday changed its outlook on CVS Caremark Corp.'s rating to positive from stable and affirmed all existing ratings.
|
Health Management Associates, Inc. Announces Pricing of Offering of $225 Million Convertible Senior Subordinated Notes Due 2028
Friday, May 16, 2008, 8:38 pm ET; Source: Business Week via Yahoo!
Published: 5/16/2008
Health Management Associates, Inc. today announced that on May 15, 2008 it priced its offering of $225 million aggregate principal amount of its convertible senior subordinated notes due 2028.
|
|
<< Return to Home
|
|
|
|
|
|
MARKET REPORT
